differences were observed with lower amplitudes in HHb signalss for less fit subjects. In control groups, middle aged and young subjects had significant higher performances in VO2max, most of cognitive tests and higher amplitudes changes for NIRS indices while exercising.
Objective:
(1) To describe the vascular abnormalities assessed carotid and brachial arteries by ultrasound in a population of children with a major sickle cell syndrome (SS). (2) To compare with controls (children of the same age with no cardiovascular risk factor). (3) To compare vascular parameters with clinical, biological and transcranial Doppler data.
Study population:
Thirty two patients with SCA were prospectively enrolled. Mean age was 12,3±4,5 years. Patients with SCA were closely matched for age, gender, to 50 healthy AA subjects. Carotid IMT, cross sectional compliance (CSC), distensibility (CSD) and FMD were determined non-invasively and compared among the two groups.
Results: FMD was significantly decreased in SCA patients vs controls (6,2±2,9 vs 8, 2±4%, p<0,05) . Carotid IMT (0,45±0,03), CSC, CSD was comparable in SCA and controls. There was no correlation between FMD and age, number and severity of crises, hemoglobin and LDH level, transcranial Doppler.
Conclusions:
This study demonstrated endothelial dysfunction in children with SCA which could influence therapies in this population to prevent cardiovascular risk factor.
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Use of allopurinol and risk of myocardial infarction: a case-control study
Lamiae Grimaldi-Bensouda (1), Annick Alpérovitch (2), Elodie Aubrun (3), Pascal Richette (4), Pascal Hilliquin (5), Nicolas Danchin (6), Philippe-Gabriel Steg (7), Bruno Fautrel (8), Michel Rossignol (9), Lucien Abenhaim (10) (1) LA-SER and C AM and Pasteur Institute/ Inserm, Paris, France -(2) Inserm U708-europidemiology, La Pitié-Salpêtrière Hospital, Paris, France -(3) LA-SER, Paris, France -(4) Lariboisiere Hospital, Rheumatology A, Paris, France -(5) CHU Sud-Francilien, Corbeil-Essonnes, France -(6) Hôpital Européen Georges Pompidou and Université Paris-Descartes, Coronary disease unit, Paris, France -(7) Inserm U698 and Hôpital Bichat, Paris, France -(8) Hôpital de la Pitié-Salpêtrière, Paris, France -(9) Montreal, 
) London School of Hygiene & Tropical Medicine and LA-SER Europe Ltd, London, Royaume-Uni
Background: While gout is considered as a risk factor for vascular diseases, the relation of allopurinol with the risk of cardiovascular events is controversial. In some studies, drug use was associated with an increased vascular risk, while other studies described a protective effect.
Objectives:
We conducted a case-control study to examine the relation between allopurinol use and risk of myocardial infarction (MI).
Methods: Cases (n=2277) were successive patients with a first-ever nonfatal MI referred to 63 cardiology centres throughout France between March 15, 2007 and November 30, 2010 . They were matched to 4849 controls selected in a large (12,313) general practice patient referent population. Controls had no past history of coronary heart disease and were matched to MI cases on age, gender, number of visits to a doctor in the preceding year, date of consultation (MI) and past history of high blood pressure. Data about medication use during the two preceding years, and past medical history and life habits (smoking, physical activity, etc.) were obtained from patient's standardized interview and GP records. Odds ratios (OR) and their 95% confidence interval were computed using conditional logistic regression, adjusting for classical vascular risk factors (body mass index, smoking, diabetes, physical activity).
Results: MI cases and controls had a mean age of 59 years, 76% were men and 56% reported a history of high blood pressure. High body mass index, low physical activity, smoking and diabetes were more prevalent in cases than in controls. Overall, during the two preceding years, 3.8% of controls and 3.1% of MI cases had used allopurinol, and 1.1 of both cases and controls had used another hypouricemiant. Use of allopurinol was associated with a non-significant decreased risk of MI (adjusted OR (95%CI): 0.75 (0.56 -1.01).
Conclusions:
This study showed that allopurinol use is not a risk factor for first-ever non-fatal MI and might rather be associated with a decreased risk of MI.
Atherosclerotic complications of hemodialysis in Marrakech
Dounia Benzarouel (1), Khadija Hasni (2), Mustafa El Hattaoui (1) (1) CHU Mohamed VI, cardiologie, Marrakech, Maroc -(2) CHU Mohammed VI, Marrakech, Maroc Introduction: Atherosclerotic disease are a severe complications in uremic patients. They result in particular by an increased frequency of coronary ischemic events, responsible for 8-15% of deaths. The purpose of this study is to evaluate the frequency and severity of atherosclerotic complications in this population and their associations with traditional risk factors and specific uremia.
Patients and methods: This is a multicenter cross-sectional study, only prospective 6-months from March 2011 to August 2011, including 130 hemodialysis. Complications were defined by atherosclerotic coronary artery disease, cerebrovascular disease and peripheral vascular disease. They were classified according to severity using an index of existing co morbidities (ICED). Comparison of patients with and without atherosclerotic complications was performed using SPSS software Results: The frequency of atherosclerotic complications was 29.2% (38 patients).21 patients had coronary artery disease (16.2%), 7 patients had cerebrovascular disease (5.4%) and 16 patients had cerebrovascular disease (12.3%). The mean age was 55.6 ± 8.96 years. We noted a male predominance. 6 patients were smokers, 30 patients had hypertension and 17 patients were diabetic. Dyslipidemia was found in 13 patients. Coronary angiography was performed in 13 patients showing single-vessel disease 4 patients, 2 patients vessel disease and vessel disease in 1 patient. 5 patients had an ischemic stroke which was a transient. 1 patient had a hemorrhagic stroke and one patient had a carotid stenosis. 3 patients had peripheral arterial disease confirmed and 11 patients had intermittent claudication of the lower limbs. Atherosclerotic complications were significantly associated with age (p=0.001), hypertension (p=0.048), systolic blood pressure (p=0.038), diabetes (p=0.001), dyslipidemia (p=0.024) , obesity (p=0.018), triglycerides (p=0.018) and left ventricular mass (p=0.003).
Conclusion: Uremic patients have a high incidence of atherosclerotic disease and traditional cardiovascular risk factors.
